These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38011478)
1. Rapid screening for generalized anxiety disorder in patients with migraine. Veisy F; Farahani H; Togha M; Gharaee B; Janani L; Aghebati A Curr J Neurol; 2021 Apr; 20(2):102-110. PubMed ID: 38011478 [No Abstract] [Full Text] [Related]
2. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. Seo JG; Park SP J Headache Pain; 2015; 16():97. PubMed ID: 26596588 [TBL] [Abstract][Full Text] [Related]
3. The reliability, validity and factorial structure of the Swahili version of the 7-item generalized anxiety disorder scale (GAD-7) among adults living with HIV from Kilifi, Kenya. Nyongesa MK; Mwangi P; Koot HM; Cuijpers P; Newton CRJC; Abubakar A Ann Gen Psychiatry; 2020; 19():62. PubMed ID: 33133222 [TBL] [Abstract][Full Text] [Related]
4. A Brief Online and Offline (Paper-and-Pencil) Screening Tool for Generalized Anxiety Disorder: The Final Phase in the Development and Validation of the Mental Health Screening Tool for Anxiety Disorders (MHS: A). Kim SH; Park K; Yoon S; Choi Y; Lee SH; Choi KH Front Psychol; 2021; 12():639366. PubMed ID: 33692730 [TBL] [Abstract][Full Text] [Related]
5. Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample. Kertz S; Bigda-Peyton J; Bjorgvinsson T Clin Psychol Psychother; 2013; 20(5):456-64. PubMed ID: 22593009 [TBL] [Abstract][Full Text] [Related]
6. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447 [TBL] [Abstract][Full Text] [Related]
7. [Sensitivity and specificity of the worry and anxiety questionnaire (WAQ) in a sample of health-care users in the province of Quebec]. Belleville G; Bélanger L; Ladouceur R; Morin CM Encephale; 2008 Jun; 34(3):240-8. PubMed ID: 18558144 [TBL] [Abstract][Full Text] [Related]
8. Validity and Reliability of the Turkish Version of Generalized Anxiety Disorder Scale-Revised. Gündüz A; Gündoğmuş İ; Sertçelik S; Engin BH; İşler A; Yaşar AB; Gönül H; Çipil A; Gündüz EBU Psychiatry Investig; 2021 Oct; 18(10):949-957. PubMed ID: 34619820 [TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of the traditional Chinese version of the GAD-7 in Taiwanese patients with epilepsy. Shih YC; Chou CC; Lu YJ; Yu HY J Formos Med Assoc; 2022 Nov; 121(11):2324-2330. PubMed ID: 35584970 [TBL] [Abstract][Full Text] [Related]
10. Psychometric properties and measurement invariance of the 7-item General Anxiety Disorder scale (GAD-7) in an Italian coronary heart disease population. Bolgeo T; Di Matteo R; Simonelli N; Dal Molin A; Lusignani M; Bassola B; Vellone E; Maconi A; Iovino P J Affect Disord; 2023 Aug; 334():213-219. PubMed ID: 37149049 [TBL] [Abstract][Full Text] [Related]
11. Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine. Chang HY; Jensen MP; Yang CC; Lai YH Health Qual Life Outcomes; 2019 Jun; 17(1):108. PubMed ID: 31234894 [TBL] [Abstract][Full Text] [Related]
12. Psychometric Properties of the Generalized Anxiety Disorder-7 and Generalized Anxiety Disorder-Mini in United States University Students. Byrd-Bredbenner C; Eck K; Quick V Front Psychol; 2020; 11():550533. PubMed ID: 33071867 [No Abstract] [Full Text] [Related]
13. Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine. Seo JG; Park SP J Oral Facial Pain Headache; 2017 Summer; 31(3):251-256. PubMed ID: 28738110 [TBL] [Abstract][Full Text] [Related]
14. Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. Beard C; Björgvinsson T J Anxiety Disord; 2014 Aug; 28(6):547-52. PubMed ID: 24983795 [TBL] [Abstract][Full Text] [Related]
15. The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis. Terrill AL; Hartoonian N; Beier M; Salem R; Alschuler K Int J MS Care; 2015; 17(2):49-56. PubMed ID: 25892974 [TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Polish version of the Basińska BA; Kwissa-Gajewska Z Int J Occup Med Environ Health; 2023 Nov; 36(4):493-504. PubMed ID: 37737500 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of worry: validation of a French translation of the Penn State Worry Questionnaire]. Gosselin P; Dugas MJ; Ladouceur R; Freeston MH Encephale; 2001; 27(5):475-84. PubMed ID: 11760697 [TBL] [Abstract][Full Text] [Related]
18. Onabotulinumtoxin A Improves Psychological Aspects in Chronic Migraine Patients. Al-Hashel JY; Kh Ashkanani H; Almutairi O; Bokubar FA; Mubarak S; Alwazzan S; Alroughani R; Youssry D; Farouk Ahmed S Front Neurol; 2020; 11():633355. PubMed ID: 33584525 [No Abstract] [Full Text] [Related]
19. Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia. Vrublevska J; Renemane L; Kivite-Urtane A; Rancans E Front Psychiatry; 2022; 13():972628. PubMed ID: 36276320 [TBL] [Abstract][Full Text] [Related]
20. Assessing anxiety symptom severity in Rwandese adolescents: cross-gender measurement invariance of GAD-7. Niwenahisemo LC; Hong S; Kuang L Front Psychiatry; 2024; 15():1346267. PubMed ID: 38528981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]